{"id":666,"date":"2017-11-16T14:43:24","date_gmt":"2017-11-16T12:43:24","guid":{"rendered":"http:\/\/aumed.cz\/en\/transferfaktor\/"},"modified":"2020-08-31T14:46:50","modified_gmt":"2020-08-31T12:46:50","slug":"transfer-factor","status":"publish","type":"page","link":"https:\/\/aumed.cz\/en\/transfer-factor\/","title":{"rendered":"Transfer factor"},"content":{"rendered":"

[vc_row full_width=”stretch_row” css=”.vc_custom_1510838299727{padding-top: 100px !important;padding-bottom: 0px !important;background-image: url(http:\/\/aumed.cz\/wp-content\/uploads\/2017\/11\/transferfaktor_head.jpg?id=515) !important;}”][vc_column]

TRANSFER FACTOR<\/h2><\/div>[vc_row_inner][vc_column_inner css=”.vc_custom_1469258402679{padding-top: 130px !important;}”]Aumed, a.s.<\/span><\/a><\/span><\/span>[\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1510836689593{background-color: #ffffff !important;}”][vc_column][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”]<\/p>\n

Research and development of transfer factors in the company AUMED, a.s.<\/strong><\/h2>\n

[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”]AUMED, a.s. focuses on one of its research and development activities, supported by grants, to the area of transfer factors intended for human therapy.[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1510837311180{background-color: #f9f9f9 !important;}”][vc_column][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”]<\/p>\n

WHAT ARE THE TRANSFER FACTORS?<\/strong><\/h2>\n

[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”]Transfer factors were discovered and described by Dr. Henry Sherwood Lawrence in the late 1940s. It is still an inaccurately defined mixture of many biologically active molecules carrying immunity information.<\/strong> They represent a unique type of messenger used for cell-to-cell communication in the immune system.<\/p>\n

The essence of the efficiency of transfer factors lies in the transfer of distinct cell-mediated immunity from an immuno-sufficient donor to a deficient recipient. Transfer factors have been used successfully over the past quarter of a century for treating viral, parasitic, and fungal infections, as well as immunodeficiencies, neoplasias, allergies and autoimmune diseases. Moreover, case reports in cancer treatment have been published.[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1469210658172{background-color: #e7f2f9 !important;}”][vc_column][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”]<\/p>\n

WHY RESEARCH IN THIS AREA?<\/strong><\/h2>\n

[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”]The development of legislation related to pharmaceutical issues generally puts increasing emphasis on the safety and efficacy of medicines. The research activities of transfer factors in AUMED, a.s.<\/strong> therefore focus on modernization of their preparation technology<\/strong>, more precise identification of the mechanism of their effects<\/strong>, development of more sophisticated procedures of their testing and innovation of their pharmaceutical form<\/strong>.[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1510837251554{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;background-color: #f9f9f9 !important;}”][vc_column css=”.vc_custom_1510837405088{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;}”][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”]<\/p>\n

AIM OF OUR RESEARCH<\/strong><\/h2>\n

[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”]All of these research activities should result in a transfer factor as a new medicinal product<\/strong> that meets all the criteria for advanced drugs. The innovatively enhanced immunotherapy medical product will not only have good commercial use<\/strong>, but above all a wide therapeutic application<\/strong> and good potential in a diverse range of increasing immunological diseases<\/strong>.[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]Research was also supported by the OPPIK project (PROJECT NUMBER: CZ.01.1.02\/0.0\/0.0\/16_083\/0010301).<\/strong> This project was successfully completed in 2020. The main output of the project are produced samples – lyophilized tablets containing transfer factor as an active drug substance. Learn more about the results of the project.<\/a><\/em><\/p>\n

We assume that the results of the presented project will probably be followed by a series of other tests (clinical) needed for the marketing of the drug.<\/em>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row full_width=”stretch_row” css=”.vc_custom_1510838299727{padding-top: 100px !important;padding-bottom: 0px !important;background-image: url(http:\/\/aumed.cz\/wp-content\/uploads\/2017\/11\/transferfaktor_head.jpg?id=515) !important;}”][vc_column][vc_row_inner][vc_column_inner css=”.vc_custom_1469258402679{padding-top: 130px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1510836689593{background-color: #ffffff !important;}”][vc_column][vc_empty_space height=”20px”][vc_column_text css_animation=”bottom-to-top”] Research and development…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-666","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/pages\/666"}],"collection":[{"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/comments?post=666"}],"version-history":[{"count":4,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/pages\/666\/revisions"}],"predecessor-version":[{"id":739,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/pages\/666\/revisions\/739"}],"wp:attachment":[{"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/media?parent=666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}